151 related articles for article (PubMed ID: 35288552)
1. Rescuing low frequency variants within intra-host viral populations directly from Oxford Nanopore sequencing data.
Liu Y; Kearney J; Mahmoud M; Kille B; Sedlazeck FJ; Treangen TJ
Nat Commun; 2022 Mar; 13(1):1321. PubMed ID: 35288552
[TBL] [Abstract][Full Text] [Related]
2. Rescuing Low Frequency Variants within Intra-Host Viral Populations directly from Oxford Nanopore sequencing data.
Liu Y; Kearney J; Mahmoud M; Kille B; Sedlazeck FJ; Treangen TJ
bioRxiv; 2021 Sep; ():. PubMed ID: 34518837
[TBL] [Abstract][Full Text] [Related]
3. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.
Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW
Nat Commun; 2020 Dec; 11(1):6272. PubMed ID: 33298935
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Nanopore and Synthesis-Based Next-Generation Sequencing Platforms for SARS-CoV-2 Variant Monitoring in Wastewater.
Garcia-Pedemonte D; Carcereny A; Gregori J; Quer J; Garcia-Cehic D; Guerrero L; Ceretó-Massagué A; Abid I; Bosch A; Costafreda MI; Pintó RM; Guix S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139015
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants.
Riaz N; Leung P; Barton K; Smith MA; Carswell S; Bull R; Lloyd AR; Rodrigo C
BMC Genomics; 2021 Mar; 22(1):148. PubMed ID: 33653280
[TBL] [Abstract][Full Text] [Related]
6. Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data.
Roder AE; Johnson KEE; Knoll M; Khalfan M; Wang B; Schultz-Cherry S; Banakis S; Kreitman A; Mederos C; Youn JH; Mercado R; Wang W; Chung M; Ruchnewitz D; Samanovic MI; Mulligan MJ; Lässig M; Luksza M; Das S; Gresham D; Ghedin E
mBio; 2023 Aug; 14(4):e0104623. PubMed ID: 37389439
[TBL] [Abstract][Full Text] [Related]
7. InterARTIC: an interactive web application for whole-genome nanopore sequencing analysis of SARS-CoV-2 and other viruses.
Ferguson JM; Gamaarachchi H; Nguyen T; Gollon A; Tong S; Aquilina-Reid C; Bowen-James R; Deveson IW
Bioinformatics; 2022 Feb; 38(5):1443-1446. PubMed ID: 34908106
[TBL] [Abstract][Full Text] [Related]
8. Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq.
Tshiabuila D; Giandhari J; Pillay S; Ramphal U; Ramphal Y; Maharaj A; Anyaneji UJ; Naidoo Y; Tegally H; San EJ; Wilkinson E; Lessells RJ; de Oliveira T
BMC Genomics; 2022 Apr; 23(1):319. PubMed ID: 35459088
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Illumina versus Nanopore 16S rRNA Gene Sequencing of the Human Nasal Microbiota.
Heikema AP; Horst-Kreft D; Boers SA; Jansen R; Hiltemann SD; de Koning W; Kraaij R; de Ridder MAJ; van Houten CB; Bont LJ; Stubbs AP; Hays JP
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967250
[TBL] [Abstract][Full Text] [Related]
10. Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.
Liu H; Li J; Lin Y; Bo X; Song H; Li K; Li P; Ni M
J Med Virol; 2022 Jan; 94(1):327-334. PubMed ID: 34524690
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Illumina and Oxford Nanopore Sequencing Technologies for Pathogen Detection from Clinical Matrices Using Molecular Inversion Probes.
Stefan CP; Hall AT; Graham AS; Minogue TD
J Mol Diagn; 2022 Apr; 24(4):395-405. PubMed ID: 35085783
[TBL] [Abstract][Full Text] [Related]
12. Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing.
Yan Y; Wu K; Chen J; Liu H; Huang Y; Zhang Y; Xiong J; Quan W; Wu X; Liang Y; He K; Jia Z; Wang D; Liu D; Wei H; Chen J
Virol Sin; 2021 Oct; 36(5):901-912. PubMed ID: 33851337
[TBL] [Abstract][Full Text] [Related]
13. Sequencing of SARS-CoV-2 in local transmission cases through Oxford Nanopore MinION platform from Karachi Pakistan.
Mukry SN; Ahmed S; Raza Bukhari A; Shahni A; Sufaida G; Naz A; Shamsi TS
J Infect Dev Ctries; 2021 Oct; 15(10):1376-1383. PubMed ID: 34780358
[TBL] [Abstract][Full Text] [Related]
14. ONTdeCIPHER: an amplicon-based nanopore sequencing pipeline for tracking pathogen variants.
Cherif E; Thiam FS; Salma M; Rivera-Ingraham G; Justy F; Deremarque T; Breugnot D; Doudou JC; Gozlan RE; Combe M
Bioinformatics; 2022 Mar; 38(7):2033-2035. PubMed ID: 35080622
[TBL] [Abstract][Full Text] [Related]
15. DNAscent v2: detecting replication forks in nanopore sequencing data with deep learning.
Boemo MA
BMC Genomics; 2021 Jun; 22(1):430. PubMed ID: 34107894
[TBL] [Abstract][Full Text] [Related]
16. BoardION: real-time monitoring of Oxford Nanopore sequencing instruments.
Bruno A; Aury JM; Engelen S
BMC Bioinformatics; 2021 May; 22(1):245. PubMed ID: 33985424
[TBL] [Abstract][Full Text] [Related]
17. cgMSI: pathogen detection within species from nanopore metagenomic sequencing data.
Zhu X; Zhao L; Huang L; Yang W; Wang L; Yu R
BMC Bioinformatics; 2023 Oct; 24(1):387. PubMed ID: 37821827
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR.
Ranasinghe D; Jayadas TTP; Jayathilaka D; Jeewandara C; Dissanayake O; Guruge D; Ariyaratne D; Gunasinghe D; Gomes L; Wijesinghe A; Wijayamuni R; Malavige GN
PLoS One; 2022; 17(4):e0265220. PubMed ID: 35377884
[TBL] [Abstract][Full Text] [Related]
19. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing.
Capraru ID; Romanescu M; Anghel FM; Oancea C; Marian C; Sirbu IO; Chis AR; Ciordas PD
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557043
[No Abstract] [Full Text] [Related]
20. Third-Generation Sequencing in the Clinical Laboratory: Exploring the Advantages and Challenges of Nanopore Sequencing.
Petersen LM; Martin IW; Moschetti WE; Kershaw CM; Tsongalis GJ
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31619531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
